
Daniel Flora/accru.org
Mar 5, 2025, 09:58
Daniel Flora: T-cell inhibition plus hypomethylation for locally advanced HER2-negative breast cancer
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a paper he and his colleagues authored on LinkedIn:
“Thanks to St Elizabeth patients who participated in this clinical trial helping us find new ways to target breast cancer with immunotherapy. Also super cool to share authorship with my Emory University bud and rockstar oncologist Andrew Poklepovic.”
Authors: Harry D Bear et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 5, 2025, 09:34
Mar 5, 2025, 09:21
Mar 5, 2025, 09:15
Mar 5, 2025, 09:12
Mar 5, 2025, 09:07
Mar 5, 2025, 08:58